Connection

Perry Molinoff to Binding Sites

Back to Details
This is a "connection" page, showing publications Perry Molinoff has written about Binding Sites.
Perry Molinoff
Connection Strength
0.281
Binding Sites
  1. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells. J Pharmacol Exp Ther. 1994 Apr; 269(1):246-55.
    View in: PubMed
    Score: 0.025
  2. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies. J Pharmacol Exp Ther. 1993 Feb; 264(2):1002-11.
    View in: PubMed
    Score: 0.023
  3. An antagonist/partial agonist at the polyamine recognition site of the N-methyl-D-aspartate receptor that alters the properties of the glutamate recognition site. J Pharmacol Exp Ther. 1992 Aug; 262(2):539-44.
    View in: PubMed
    Score: 0.022
  4. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site. Mol Pharmacol. 1992 Apr; 41(4):785-92.
    View in: PubMed
    Score: 0.022
  5. Inhibition of binding of [3H]PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation. J Pharmacol Exp Ther. 1991 Oct; 259(1):337-44.
    View in: PubMed
    Score: 0.021
  6. Modulation of the NMDA receptor by polyamines. Life Sci. 1991; 48(6):469-98.
    View in: PubMed
    Score: 0.020
  7. Synthesis and applications of an aldehyde-containing analogue of SCH-23390. Bioconjug Chem. 1990 Nov-Dec; 1(6):394-9.
    View in: PubMed
    Score: 0.020
  8. Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor. Neuron. 1990 Aug; 5(2):199-208.
    View in: PubMed
    Score: 0.020
  9. Effects of polyamines on the binding of [3H]MK-801 to the N-methyl-D-aspartate receptor: pharmacological evidence for the existence of a polyamine recognition site. Mol Pharmacol. 1989 Oct; 36(4):575-81.
    View in: PubMed
    Score: 0.018
  10. Characterization of binding sites for [3H]spiroperidol. Biochem Pharmacol. 1987 Oct 01; 36(19):3255-64.
    View in: PubMed
    Score: 0.016
  11. Down regulation of beta adrenergic receptors in S49 lymphoma cells induced by atypical agonists. J Pharmacol Exp Ther. 1986 Dec; 239(3):654-60.
    View in: PubMed
    Score: 0.015
  12. Multiple sites of action of ethanol on adenylate cyclase. J Pharmacol Exp Ther. 1983 Dec; 227(3):551-6.
    View in: PubMed
    Score: 0.012
  13. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum. Mol Pharmacol. 1983 Mar; 23(2):303-9.
    View in: PubMed
    Score: 0.012
  14. Beta-adrenergic receptor subtypes: properties, distribution, and regulation. Annu Rev Neurosci. 1981; 4:419-61.
    View in: PubMed
    Score: 0.010
  15. Ontogeny of beta 1- and beta 2-adrenergic receptors in rat cerebellum and cerebral cortex. Brain Res. 1980 Apr 28; 188(2):357-68.
    View in: PubMed
    Score: 0.010
  16. Cholinergic receptors in Torpedo. Neurosci Res Program Bull. 1973 Jun; 11(3):253-7.
    View in: PubMed
    Score: 0.006
  17. Characterization of beta-adrenergic receptors in cultured human trabecular cells and in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1989 Jan; 30(1):51-7.
    View in: PubMed
    Score: 0.004
  18. Effects of isoproterenol on the development of beta-adrenergic receptors in brain cell aggregates. Brain Res. 1981 Feb 23; 207(1):174-7.
    View in: PubMed
    Score: 0.003
  19. Isolation of the cholinergic receptor protein of Torpedo electric tissue. Nature. 1971 Feb 19; 229(5286):554-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.